Back
Surgery Partners Stock Price Chart
Sponsored
SGRY
Sponsored
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
SGRY
Surgery Partners
Last Price:
31.39
Seasonality Move:
9.64%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGRY is experiencing slight buying pressure.
Surgery Partners Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.55 | Buy |
20-day SMA: | 30.69 | Buy |
50-day SMA: | 29.46 | Buy |
200-day SMA: | 29.08 | Buy |
8-day EMA: | 30.84 | Buy |
20-day EMA: | 30.58 | Buy |
50-day EMA: | 29.49 | Buy |
200-day EMA: | 29.1 | Buy |
Surgery Partners Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 58.16 | Buy |
Chaikin Money Flow: | 299128 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.96 - 31.92) | Buy |
Bollinger Bands (100): | (24.68 - 30.12) | Buy |
Surgery Partners Technical Analysis
Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Surgery Partners Stock
Is Surgery Partners Stock a Buy?
- Surgery Partners share price is 31.86 while SGRY 8-day simple moving average is 30.55, which is a Buy signal.
- The stock price of SGRY is 31.86 while Surgery Partners 20-day SMA is 30.69, which makes it a Buy.
- Surgery Partners 50-day simple moving average is 29.46 while SGRY share price is 31.86, making it a Buy technically.
- SGRY stock price is 31.86 and Surgery Partners 200-day simple moving average is 29.08, creating a Buy signal.
SGRY Technical Analysis vs Fundamental Analysis
Buy
61
Surgery Partners (SGRY)
is a Buy
Is Surgery Partners a Buy or a Sell?
-
Surgery Partners stock is rated a Buy
The current Surgery Partners [SGRY] share price is $31.86. The Score for SGRY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Surgery Partners Stock Info
Market Cap:
4.05B
Price in USD:
31.86
Share Volume:
655.54K
Surgery Partners 52-Week Range
52-Week High:
36.92
52-Week Low:
22.05
Buy
61
Surgery Partners (SGRY)
is a Buy
Surgery Partners Share Price Forecast
-
What is the Surgery Partners stock price today?
The Surgery Partners stock price is 31.86 USD today. -
Will SGRY stock go up or go down?
Surgery Partners> share price is forecast to RISE/FALL based on technical indicators -
Is Surgery Partners overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Surgery Partners is not overvalued.
Is Surgery Partners Stock a Buy?
- Surgery Partners share price is 31.86 while SGRY 8-day exponential moving average is 30.84, which is a Buy signal.
- The stock price of SGRY is 31.86 while Surgery Partners 20-day EMA is 30.58, which makes it a Buy.
- Surgery Partners 50-day exponential moving average is 29.49 while SGRY share price is 31.86, making it a Buy technically.
- SGRY stock price is 31.86 and Surgery Partners 200-day simple moving average is 29.10, creating a Buy signal.
Fundamental Analysis of Surgery Partners
Is Surgery Partners a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.06 per share, an increase this year of $0.13 per share, and an increase next year of $0.25 per share.
Technical Analysis of Surgery Partners
Should I short Surgery Partners stock?
- SGRY Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting Surgery Partners is a Buy
- Surgery Partners Relative Strength Index (RSI) is 58.16, which suggest Surgery Partners is overbought
- The Bollinger Bands (25) for Surgery Partners is (28.96 - 31.92), which suggest Surgery Partners is a Buy
- The Bollinger Bands (100) for Surgery Partners is (24.68 - 30.12), which suggest Surgery Partners is a Buy
* Surgery Partners stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.